Enantiomer binding sites

FIGURE 17 14 (a) Binding sites of enzyme discriminate between prochiral faces of substrate One prochiral face can bind to the enzyme better than the other (b) Reaction attaches fourth group to substrate producing only one enantiomer of chiral product... 

In the elucidation of retention mechanisms, an advantage of using enantiomers as templates is that nonspecific binding, which affects both enantiomers equally, cancels out. Therefore the separation factor (a) uniquely reflects the contribution to binding from the enantioselectively imprinted sites. As an additional comparison the retention on the imprinted phase is compared with the retention on a nonimprinted reference phase. The efficiency of the separations is routinely characterized by estimating a number of theoretical plates (N), a resolution factor (R ) and a peak asymmetry factor (A ) [19]. These quantities are affected by the quality of the packing and mass transfer limitations, as well as of the amount and distribution of the binding sites. 

High yields are possible due to the large capacity of the ChiraLig for the single enantiomer on each load cycle. A significant percentage of the available binding sites are used in each cycle to bind the eutomer. 

A fourth important pharmacophoric element was established for the non-classical cannabinoid series in the form of a southern aliphatic hydroxyl group. Addition of this group to (192) resulted in the high-affinity CBi and CB2 receptor full agonist CP 55,940 (193) [129, 133], the tritiated form of which was used to first demonstrate specific cannabinoid binding sites in brain tissue [134]. Its enantiomer, CP 56,667 (194) has lower affinity for the CBi receptor (Table 6.17). 

Although anosmias to these compounds occur at similar levels, some communicative value may arise from the persistence of signal emissions which are not enantiomerically pure (Carman, 1993 Wysocki et al., 1999). In secreted mixtures, the alternate versions of such compounds are produced in a constant ratio since they have identical volatility and hence provide stable informational content to the receiver. Support for this idea comes from the results of the NMR mapping of the BT binding site within the MUP1 carrier (Zidek et al., 1999). Here the protein-ligand complex does exist in the expected ratio, and for both enantiomers, although the orientation of the bound thiazole was interpreted as opposite to that indicated by previous X-ray analyses. 

Soltes, L., Sebille, B. (1997). Reversible binding interactions between the tryptophan enantiomers and albumins of different animal species as determined by novel high performance liquid chromatographic methods an attempt to localize the d- and L-tryptophan binding sites on the human serum albumin polypeptide chain by using protein fragments. Chirality 9, 373-379. 

Figure 5.7 Only one of the two amino acid enantiomers shown can achieve three-point binding with the hypothetical binding site (e.g., in an enzyme). 

Linear Dichroism. The AA spectra of covalent adducts derived from the binding of racemic anti-BaPDE and of the enantiomer (+)-anti-BaPDE to DNA are positive in sign and similar in shape (5,31) this is expected since the (+) enantiomer binds more extensively to DNA than the (-) enantiomer (15). These covalent adducts are therefore of the site II type. 

Formyl-substituted aminoindolizine (3 )-286 displayed a K value of 6.0 nM for the high-affinity dopamine D3 binding site. In contrast, D3 affinity of the enantiomer (R)-286 was 300-fold lower <2001BML2863>. 

The binding sites of most enzymes and receptors are highly stereoselective in recognition and reaction with optical isomers (J, 2 ), which applies to natural substrates and synthetic drugs as well. The principle of enantiomer selectivity of enzymes and binding sites in general exists by virtue of the difference of free enthalpy in the interaction of two optical antipodes with the active site of an enzyme. As a consequence the active site by itself must be chiral because only formation of a diasteromeric association complex between substrate and active site can result in such an enthalpy difference. The building blocks of enzymes and receptors, the L-amino acid residues, therefore ultimately represent the basis of nature s enantiomer selectivity. 

Boonen G, Ferger B, Kuschinsky K, Haberlein H. (1998). In vivo effects of the kavalactones (+)-dihydromethysticin and (H-/-)-kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions. Planta Med. 64(6) 507-10. Boonen G, Haberlein H. (1998). Influence of genuine kavalactone enantiomers on the GABA-A binding site. Planta Med. 64(6) 504-6. 

In Equation 1.15, q represents the adsorbed amount of solute, ns and qs are the saturation capacities (number of accessible binding sites) for site 1 (nonstereoselect-ive, subscript ns) and site 2 (stereoselective, subscript s), and fens and bs are the equilibrium constants for adsorption at the respective sites [54]. It is obvious that only the second term in this equation is supposed to be different for two enantiomers. Expressed in terms of linear chromatography conditions (under infinite dilution where the retention factor is independent of the loaded amount of solute) it follows that the retention factor k is composed of at least two distinct major binding increments corresponding to nonstereoselective and stereoselective sites according to the following... 

The chiral distinction capability of cinchonan carbamate CSPs for underivatized amino acids has not been fully elucidated yet, in contrast to the large embodiment of A-acylated and A-arylated amino acid derivatives vide infra). However, it seems that chiral amino acids can be successfully resolved into enantiomers if the amino acid side chain R residue) contains a functionality that represents a strongly interactive binding site with the selector such as an extended aromatic ring system like in thyroxin (T4). 

Thus, the anticholinergic activity of the alkaloid hyoscyamine is almost entirely confined to the (—)-isomer, and the (+)-isomer is almost devoid of activity. The racemic ( )-form, atropine, has approximately half the activity of the laevorotatory enantiomer. An anticholinergic drug blocks the action of the neurotransmitter acetylcholine, and thus occupies the same binding site as acetylcholine. The major interaction with the receptor involves that part of the molecule that mimics acetylcholine, namely the appropriately positioned ester and amine groups. The chiral centre is adjacent to the ester, and also influences binding to the receptor. 

---